We have news of two upcoming retractions, both following critiques on PubPeer.
PLOS ONE is retracting a 2012 paper by researchers at the Istituto Superiore di Sanità in Rome and the World Health Organization’s International Agency for Research on Cancer in Lyon, France, “Interferon-β Induces Cellular Senescence in Cutaneous Human Papilloma Virus-Transformed Human Keratinocytes by Affecting p53 Transactivating Activity.”
PubPeer commenters first left critiques of the paper on August 6 of last year, noting likely splicing and other manipulation of images. Several days later, pseudonymous whistleblower Claire Francis contacted the journal to flag similar issues. On Wednesday of this week, a journal representative emailed Francis to say the paper would be retracted: Continue reading “All very painful:” Two retractions to watch for, in eLife and PLOS ONE
Researchers in China have retracted a 2016 paper in Oncology Letters on the anti-cancer properties of aspirin because, well, it was a disaster from top to bottom. 

Publishers love their
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a 

When Venkata Sudheer Kumar Ramadugu, then a postdoc at the University of Michigan, admitted to the university on June 28 of last year that he had committed research misconduct in a paper that appeared in 